Transcriptomics in Early and Invasive Breast Cancer: A Systematic Review

This systematic review explores the role of transcriptomics in early and invasive breast cancer, focusing on gene expression profiling, microRNAs, and tumor microenvironment interactions. Using Synthory.AI, 31 articles from PubMed and PubMed Central™ were analyzed to assess the prognostic utility of the 21-gene Recurrence Score and miRNA signatures. The findings underscore their potential in patient stratification and clinical decision-making. However, challenges such as small sample sizes and retrospective data limit the generalizability of results. Future research should emphasize larger cohorts and prospective designs to enhance biomarker validation and clinical relevance, ultimately aiming to improve patient outcomes.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-01
DOI
https://doi.org/10.5281/zenodo.15033711
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transcriptomics in Early and Invasive Breast Cancer: A Systematic Review

Zenodo (CERN European Organization for Nuclear Research)
Breast Cancer Treatment Studies
article

Transcriptomics in Early and Invasive Breast Cancer: A Systematic Review

article en

Abstract

This systematic review explores the role of transcriptomics in early and invasive breast cancer, focusing on gene expression profiling, microRNAs, and tumor microenvironment interactions. Using Synthory.AI, 31 articles from PubMed and PubMed Central™ were analyzed to assess the prognostic utility of the 21-gene Recurrence Score and miRNA signatures. The findings underscore their potential in patient stratification and clinical decision-making. However, challenges such as small sample sizes and retrospective data limit the generalizability of results. Future research should emphasize larger cohorts and prospective designs to enhance biomarker validation and clinical relevance, ultimately aiming to improve patient outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Peace, Justice and strong institutions
Openalex Percentile: Top 44%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Transcriptomics in Early and Invasive Breast Cancer: A Systematic Review · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS